巨细胞动脉炎中的脑血管意外:来自ARTESER注册研究的患病率及预测因素
ARTESER是一项西班牙多中心注册研究,纳入2013年6月至2019年3月诊断的1540例巨细胞动脉炎(GCA)患者,旨在确定脑血管意外(CVA)的患病率及预测因素。CVA发生于61例(3.96%),其中38例(62.3%)累及椎基底动脉区域,21例(34.4%)累及颈动脉区域。与CVA相关的因素包括短暂性脑缺血发作(TIA)(OR 8.63;95%CI 2.877-25.86)、大血管(LV)受累(OR 2.79;95%CI 1.421-5.465)和伴随视觉表现(OR 2.73;95%CI 1.427-5.235);CVA患者随访期间死亡风险显著更高(18% vs 8.8%;P=0.014)。
要点
- GCA患者中CVA患病率为3.96%,其中椎基底动脉区域受累占62.3%,颈动脉区域占34.4%。
- TIA(OR 8.63)、大血管受累(OR 2.79)和视觉表现(OR 2.73)与CVA风险增加相关。
- CVA患者随访期间死亡风险显著高于无CVA患者(18% vs 8.8%;P=0.014)。
核心结论
- GCA患者中CVA患病率低,但增加死亡风险;TIA、大血管受累和视觉表现是与CVA风险增加相关的因素。
研究设计与样本
- ARTESER是一项西班牙全国多中心注册研究,由西班牙风湿病学会资助,纳入2013年6月至2019年3月诊断的GCA患者。
- 收集诊断时的人口学、临床表现(包括CVA发生及位置)、实验室、组织学和影像学资料,比较有无CVA的患者并进行多因素logistic回归分析。
- 共纳入1540例GCA患者进行分析,平均年龄77.1岁,女性占70%。
主要发现
- CVA发生于61例(3.96%),其中38例(62.3%)累及椎基底动脉区域,21例(34.4%)累及颈动脉区域。
- 与CVA相关的因素包括TIA(OR 8.63;95%CI 2.877-25.86)、大血管受累(OR 2.79;95%CI 1.421-5.465)和伴随视觉表现(OR 2.73;95%CI 1.427-5.235)。
- CVA患者随访期间死亡风险显著更高(18% vs 8.8%;P=0.014)。
- CVA患者诊断时平均泼尼松剂量显著更高(433.9 mg vs 216 mg;P<0.001),随访期间累积泼尼松剂量也显著更高(11 203.9 mg vs 8,194.1 mg;P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence and predictive factors of cerebrovascular accidents (CVA) in GCA. METHODS: ARTESER is a large Spanish multicentre registry including patients with GCA from across the entire country diagnosed between June 2013 and March 2019 and sponsored by the Spanish Society of Rheumatology. The variables collected at diagnosis were demographics, clinical manifestations (including the occurrence and location of CVA), laboratory, histology and imaging findings. Patients with and without CVA were compared in a bivariate analysis. Multivariate logistic regression was performed to determine potential predictive factors of CVA. RESULTS: A total of 1540 patients with GCA were included for analysis (mean age 77.1 years, 70% females). CVA occurred in 61 (3.96%), of whom 38 (62.3%) involved the vertebrobasilar territory and 21 (34.4%) the carotid territory. The factors associated with CVA were the occurrence of transient ischaemic attack (TIA) [odds ratio (OR) 8.63; 95% CI 2.877-25.86], large vessel (LV) involvement (OR 2.79; 95% CI 1.421-5.465) and the presence of concomitant visual manifestations (OR 2.73; 95% CI 1.427-5.235). The risk of death during follow-up was significantly higher in patients with CVA (18% vs 8.8%; P = 0.014). Patients with CVA received significantly higher mean prednisone (mg) dose at diagnosis (433.9 vs 216; P < 0.001) and cumulative prednisone dose during follow-up (11 203.9 vs 8,194.1; P < 0.001). CONCLUSION: The prevalence of CVA in patients with GCA is low, but increases the risk of mortality. The presence of TIA, LV involvement and visual manifestations are factors associated with increased risk of CVA.
引用
- Martín-Gutiérrez A, Molina-Collada J, Domínguez-Álvaro M, et al. Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry. Rheumatology (Oxford). 2025. PMID: 39918980. doi:10.1093/rheumatology/keaf051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。